Breaking News, Collaborations & Alliances

Lonza, ABL Bio Partner to Develop and Manufacture Bispecific Antibody Product

Lonza supports development and manufacturing of ABL Bio’s bispecific antibody candidate from DNA to potential IND application.

Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, entered into an agreement with ABL Bio, a Korean biologics company with a focus on bispecific antibodies for immuno-oncology and neurodegenerative diseases. The collaboration agreement supports the development and manufacturing of ABL Bio’s new bispecific antibody product. As part of the collaboration, Lonza provides ABL Bio with an integrated service offering to support its bispecific antib...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters